T1	Intervention 327 447	6 cycles of either estradiol (2mg)+trimegestone (0.5mg) (T-group) or estradiol (2mg)+dydrogesterone (10mg) (DYDR group).
T2	Intervention 448 550	Cardiovascular risk markers were measured before, after cycle 1, 3 and 6 and at 4 weeks post-treatment
